Opiate dependency in pregnancy

Siney, Catherine; Kidd, Mervyn; Walkinshaw, Stephen; Morrison, Clive L.; Manasse, Paul

doi:10.12968/bjom.1995.3.2.69

Cited by 8 publications

(4 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our work appears to support the ®ndings shown in other studies, [2], [6], which suggest that the most important mitigators against poor neonatal outcome in drug-using women is improved antenatal care, with in this case multiple services being provided in one clinic. …”

Section: Discussionsupporting

confidence: 89%

Outcome predictors in pregnant opiate and polydrug users

McCarthy

Siney

Shaw

et al. 1999

European Journal of Pediatrics

View full text Add to dashboard Cite

A retrospective case note study of 93 women was performed in order to assess the effect of maternal factors on neonatal outcome in a group of women attending a specialist clinic for pregnant drug users. There were no significant differences in outcome for chaotic drug users compared with non-chaotic drug users, or for cocaine users compared with non-cocaine using drug users. Women who reduced their methadone dose during pregnancy delivered babies of significantly higher birth weight than those whose methadone dose remained the same or increased (median 3027 g, range 1780-3629 g vs 2645 g, range 580-3720 g). Women who abused benzodiazepines during pregnancy produced babies of significantly lower birth weight than those women who did not use benzodiazepines (median 2100 g, range 580-3520 g vs 2767 g, range 1530-3720 g). The results of this study give healthcare staff evidence to use in encouraging drug-using women to avoid benzodiazepines during pregnancy and to reduce their methadone dosage. The treatment received from a specialist clinic may mitigate against some of the other recognised effects of drug use during pregnancy.

show abstract

Section: Discussionsupporting

confidence: 89%

Outcome predictors in pregnant opiate and polydrug users

McCarthy

Siney

Shaw

et al. 1999

European Journal of Pediatrics

View full text Add to dashboard Cite

show abstract

“…3,4,20,44 Neonatal outcomes are better for infants of substance using mothers if the women have been engaged in antenatal care, 1,7 and some authors suggest that with appropriately targeted services, opiate users may be able to expect similar outcomes to those non-drug using women of similar social circumstances. 45,46 Frequency of access to medical care may also be a contributing factor. 6 In our sample, the infants of women who had no antenatal care were more likely to have at least one neonatal morbidity compared to those who had antenatal care, however these findings were not statistically significant and should be viewed with caution given the small numbers.…”

Section: Discussionmentioning

confidence: 99%

Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit

Blandthorn

Forster

Love³

2011

Women and Birth

View full text Add to dashboard Cite

“…The results indicated the importance of multi-agency care available in a service as a "one-stop shop" as each client had usually developed a close relationship with only one professional. It is reported that staff's attitudes and relationships with clients are often perceived by clients as more important than the quality of the medical care [ 22 , 38 ].…”

Section: Discussionmentioning

confidence: 99%

A qualitative study of an integrated maternity, drugs and social care service for drug-using women

Hall

Teijlingen

2006

BMC Pregnancy Childbirth

View full text Add to dashboard Cite

BackgroundThe care of drug-using pregnant women is a growing health and social care concern in many countries. A specialist clinic was established offering multidisciplinary care and advice to pregnant drug users in and around Aberdeen (UK) in 1997. The majority of women stabilise and reduce their drug use. By determining the needs and views of the women more appropriate services and prevention strategies may be developed. There has been little research conducted in this area and none in Scotland.MethodsThis is a qualitative study that aimed to gain an understanding of the experiences of women drug users, seeking and receiving prenatal care and drug services from a specialist clinic. Twelve women participated in semi-structured one-to-one interviews.ResultsThe women preferred the multidisciplinary clinic (one-stop shop) to traditional prenatal care centred within General Practice. The relationships of the clients to the range of Clinic professionals and in hospital were explored as well as attitudes to Clinic care. The study participants attributed success in reducing their drug use to the combination of different aspects of care of the multi-agency clinic, especially the high level prenatal support. It is this arrangement of all aspects of care together that seem to produce better outcomes for mother and child than single care elements delivered separately. Some women reported that their pregnancy encouraged them to rapidly detoxify due to the guilt experienced. The most important aspects of the Clinic care were found to be non-judgemental attitude of staff, consistent staff, high level of support, reliable information and multi-agency integrated care.ConclusionThere is an impetus for women drug users to change lifestyle during pregnancy. The study highlighted a need for women to have access to reliable information on the effects of drugs on the baby.Further research is required to determine whether positive outcomes related to clinic attendance in the prenatal period are sustained in the postnatal period. Early referral to a specialist clinic is of benefit to the women, as they reported to receive more appropriate care, especially in relation to their drug use. A greater awareness of needs of the pregnant drug user could help the design of more effective prevention strategies.

show abstract

Opiate dependency in pregnancy

Abstract: A retrospective study of 103 opiate-dependent women in Liverpool compared their outcomes of pregnancy with those of non-drug-misusing controls matched by age, parity and postal code. The study group were all on a methadone programme and received regular antenatal care.

Cited by 8 publications

References 3 publications

Outcome predictors in pregnant opiate and polydrug users

Outcome predictors in pregnant opiate and polydrug users

Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit

A qualitative study of an integrated maternity, drugs and social care service for drug-using women

Contact Info

Product

Resources

About